Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by <i>EP300</i> mutations
-
- Patricia Fergelot
- Department of Genetics, and INSERM U1211 University Hospital of Bordeaux Bordeaux France
-
- Martine Van Belzen
- Department of Clinical Genetics Leiden University Medical Center Leiden The Netherlands
-
- Julien Van Gils
- Department of Genetics University Hospital Center Bordeaux France
-
- Alexandra Afenjar
- Unité de Génétique Hospital Armand Trousseau‐La Roche‐Guyon AP‐HP Paris France
-
- Christine M. Armour
- Regional Genetics Unit Children's Hospital of Eastern Ontario Ottawa Canada
-
- Benoit Arveiler
- Department of Genetics, and INSERM U1211 University Hospital of Bordeaux Bordeaux France
-
- Lex Beets
- Department of Pediatrics Academic Medical Center Amsterdam The Netherlands
-
- Lydie Burglen
- Unité de Génétique Hospital Armand Trousseau‐La Roche‐Guyon AP‐HP Paris France
-
- Tiffany Busa
- Unité de Génétique Clinique Hospital La Timone AP‐HM Marseille France
-
- Marie Collet
- Département de Génétique Hospital Necker‐Enfants Malades AP‐HP Paris France
-
- Julie Deforges
- Department of Genetics University Hospital Center Bordeaux France
-
- Bert B. A. de Vries
- Department of Human Genetics, Donders Centre for Neuroscience Radboud University Medical Center Nijmegen The Netherlands
-
- Elena Dominguez Garrido
- Center for Biomedical Research Logrono‐La Rioja Spain
-
- Nathalie Dorison
- Departement de Neuropédiatrie Institut Jérôme Lejeune Paris France
-
- Juliette Dupont
- Serviço de Genética Departamento de Pediatria Hospital de Santa Maria CHLN Lisboa Portugal
-
- Christine Francannet
- Service de Génétique Médicale CHU Estaing Clermont‐Ferrand France
-
- Sixto Garciá‐Minaúr
- Institute of Medical and Molecular Genetics University Hospital La Paz Madrid Spain
-
- Elisabeth Gabau Vila
- Genetics Clinic Hospital de Sabadell Corporació Sanitària Parc Taulí Sabadell Spain
-
- Samuel Gebre‐Medhin
- Division of Clinical Genetics Department of Laboratory Medicine Lund University Lund Sweden
-
- Blanca Gener Querol
- Hospital de Cruces Baracaldo Spain
-
- David Geneviève
- Service de Génétique Médicale Hospital Arnaud de Villeneuve CHU Montpellier Montpellier France
-
- Marion Gérard
- Service de Génétique Hospital Clémenceau CHU de Caen, Caen France
-
- Cristina Giovanna Gervasini
- Department of Medical Genetics University of Milan Milan Italy
-
- Alice Goldenberg
- Unité de Génétique Clinique Hospital Charles Nicolle CHU Rouen, Rouen France
-
- Dragana Josifova
- Department of Medical Genetics Guy's and St Thomas Hospital London United Kingdom
-
- Katherine Lachlan
- Wessex Clinical Genetics Service Princess Anne Hospital Southampton United Kingdom
-
- Saskia Maas
- Department of Pediatrics Academic Medical Center Amsterdam The Netherlands
-
- Bruno Maranda
- Laboratoire de Médecine Génétique CHUQ Pavillon CHUL Saint Foy Canada
-
- Jukka S. Moilanen
- PEDEGO Research Unit, and Medical Research Center Oulu Department of Clinical Genetics University of Oulu Oulu University Hospital Oulu Finland
-
- Ann Nordgren
- Department of Molecular Medicine and Surgery, and Center for Molecular Medicine Karolinska University Hospital Stockholm Sweden
-
- Philippe Parent
- Département de Pédiatrie et Génétique Médicale Hospital Augustin Morvan CHU Brest Brest France
-
- Julia Rankin
- Department of Clinical Genetics Royal Devon and Exeter NHS Foundation Trust Exeter United Kingdom
-
- Willie Reardon
- Our Lady's Hospital for Sick Children Crumlin Ireland
-
- Marlène Rio
- Unité de Génétique Clinique Hospital La Timone AP‐HM Marseille France
-
- Joëlle Roume
- Unité de Génétique Médicale CHI Poissy Saint Germain en Laye France
-
- Adam Shaw
- Department of Medical Genetics Guy's and St Thomas Hospital London United Kingdom
-
- Robert Smigiel
- Department of Paediatrics Wroclaw Medical University Wroclaw Poland
-
- Amaia Sojo
- Hospital de Cruces Baracaldo Spain
-
- Benjamin Solomon
- Division of Medical Genomics Inova Translational Medical Institute Falls Church
-
- Agnieszka Stembalska
- Department of Genetics Wroclaw Medical University Wroclaw Poland
-
- Constance Stumpel
- Department of Clinical Genetics and School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands
-
- Francisco Suarez
- Service de Génétique Hospital Virgen de la Salud Toledo Spain
-
- Paulien Terhal
- Department of Medical Genetics University Medical Centre Utrecht Utrecht The Netherlands
-
- Simon Thomas
- Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury United Kingdom
-
- Renaud Touraine
- Service de Génétique Clinique et Moléculaire CHU Hôpital‐Nord Saint‐Etienne France
-
- Alain Verloes
- Département de Génétique CHU Robert Debré AP‐HP Paris France
-
- Catherine Vincent‐Delorme
- Service de Génétique Médicale Hospital d'Arras CHU de Lille Arras France
-
- Josephine Wincent
- Department of Molecular Medicine and Surgery, and Center for Molecular Medicine Karolinska University Hospital Stockholm Sweden
-
- Dorien J. M. Peters
- Department of Clinical Genetics Leiden University Medical Center Leiden The Netherlands
-
- Oliver Bartsch
- Institute of Human Genetics University Medical Centre Mainz Germany
-
- Lidia Larizza
- Department of Health Sciences University of Milan Milan Italy
-
- Didier Lacombe
- Department of Genetics, and INSERM U1211 University Hospital of Bordeaux Bordeaux France
-
- Raoul C. Hennekam
- Department of Pediatrics Academic Medical Center Amsterdam The Netherlands
説明
<jats:sec><jats:label /><jats:p>Rubinstein–Taybi syndrome (RSTS) is a developmental disorder characterized by a typical face and distal limbs abnormalities, intellectual disability, and a vast number of other features. Two genes are known to cause RSTS, <jats:italic>CREBBP</jats:italic> in 60% and <jats:italic>EP300</jats:italic> in 8–10% of clinically diagnosed cases. Both paralogs act in chromatin remodeling and encode for transcriptional co‐activators interacting with >400 proteins. Up to now 26 individuals with an <jats:italic>EP300</jats:italic> mutation have been published. Here, we describe the phenotype and genotype of 42 unpublished RSTS patients carrying <jats:italic>EP300</jats:italic> mutations and intragenic deletions and offer an update on another 10 patients. We compare the data to 308 individuals with <jats:italic>CREBBP</jats:italic> mutations. We demonstrate that <jats:italic>EP300</jats:italic> mutations cause a phenotype that typically resembles the classical RSTS phenotype due to <jats:italic>CREBBP</jats:italic> mutations to a great extent, although most facial signs are less marked with the exception of a low‐hanging columella. The limb anomalies are more similar to those in <jats:italic>CREBBP</jats:italic> mutated individuals except for angulation of thumbs and halluces which is very uncommon in <jats:italic>EP300</jats:italic> mutated individuals. The intellectual disability is variable but typically less marked whereas the microcephaly is more common. All types of mutations occur but truncating mutations and small rearrangements are most common (86%). Missense mutations in the HAT domain are associated with a classical RSTS phenotype but otherwise no genotype–phenotype correlation is detected. Pre‐eclampsia occurs in 12/52 mothers of <jats:italic>EP300</jats:italic> mutated individuals versus in 2/59 mothers of CREBBP mutated individuals, making pregnancy with an <jats:italic>EP300</jats:italic> mutated fetus the strongest known predictor for pre‐eclampsia. © 2016 Wiley Periodicals, Inc.</jats:p></jats:sec>
収録刊行物
-
- American Journal of Medical Genetics Part A
-
American Journal of Medical Genetics Part A 170 (12), 3069-3082, 2016-09-20
Wiley